Scynexis (SCYX) EBIT Margin (2013 - 2026)
Scynexis (SCYX) posted EBIT Margin of -3308.51% for Q2 2026, down 2607.56 percentage points from -700.95% a year earlier.
Powered by 
Analysis
Scynexis (SCYX) EBIT Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Scynexis was -117.61%, up 1004.06 percentage points year-over-year; for FY2025, it came in at -78.03%, up 912.82 percentage points from FY2024.
- Annual EBIT Margin shows a four-year change of +384.16 percentage points (FY2021 to FY2025).
- In prior years, Scynexis' EBIT Margin was -990.84% in FY2024 (-1042.70 pp), 51.85% in FY2023 (+1736.34 pp), -1684.48% in FY2022 (-1222.29 pp) and -462.19% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBIT Margin since Q1 2025.
- On a year-over-year basis, EBIT Margin increased in two of the last seven quarters, with an average year-over-year change of -885.70 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q3 2022, with a gain of 2367.44 percentage points; the weakest was Q1 2022, with a drop of 2806.49 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Scynexis | 45.97 Mn | -25.13 Mn | - | -3,308.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,308.51% |
| Dec 31, 2025 | 56.42% |
| Sep 30, 2025 | -2,516.47% |
| Jun 30, 2025 | -700.95% |
| Mar 31, 2025 | -3,350.19% |
| Dec 31, 2024 | -824.26% |
| Sep 30, 2024 | -1,563.64% |
| Jun 30, 2024 | -1,255.03% |
| Mar 31, 2024 | -692.50% |
| Dec 31, 2023 | -397.88% |
| Sep 30, 2023 | -573.42% |
| Jun 30, 2023 | 88.63% |
| Mar 31, 2023 | -945.31% |
| Dec 31, 2022 | -1,475.13% |
| Sep 30, 2022 | -1,400.19% |
| Jun 30, 2022 | -1,643.08% |
| Mar 31, 2022 | -2,819.71% |
| Dec 31, 2021 | -3,734.84% |
| Sep 30, 2021 | -3,767.64% |
| Mar 31, 2021 | -13.23% |
API Access
Scynexis EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SCYX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SCYX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SCYX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();